Inogen, Inc.
General ticker "INGN" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $188.2M (TTM average)
Inogen, Inc. does not follow the US Stock Market performance with the rate: -6.5%.
Estimated limits based on current volatility of 1.6%: low 6.42$, high 6.63$
Factors to consider:
- Total employees count: 753 (-1.7%) as of 2025
- US accounted for 65.1% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Regulatory and compliance, Intellectual property risks, Market volatility, Market competition, Customer concentration
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.72$, 10.22$]
- 2026-12-31 to 2027-12-31 estimated range: [4.82$, 10.37$]
Financial Metrics affecting the INGN estimates:
- Positive: with PPE of -7.8 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0.25 <= 0.28
- Positive: Shareholder equity ratio, % of 64.37 > 64.23
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of 0.41 <= 0.80
Short-term INGN quotes
Long-term INGN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $315.66MM | $335.70MM | $348.67MM |
| Operating Expenses | $425.05MM | $378.22MM | $378.88MM |
| Operating Income | $-109.39MM | $-42.52MM | $-30.21MM |
| Non-Operating Income | $7.04MM | $6.04MM | $6.83MM |
| R&D Expense | $20.84MM | $21.61MM | $19.40MM |
| Income(Loss) | $-102.34MM | $-36.48MM | $-23.38MM |
| Taxes | $0.10MM | $-0.59MM | $-0.63MM |
| Net Income(Loss)* | $-102.45MM | $-35.89MM | $-22.75MM |
| Stockholders Equity | $204.81MM | $173.86MM | $192.23MM |
| Inventory | $21.84MM | $24.81MM | $25.97MM |
| Assets | $326.19MM | $296.19MM | $298.62MM |
| Operating Cash Flow | $-3.23MM | $5.91MM | $-11.22MM |
| Capital expenditure | $26.52MM | $17.09MM | $10.38MM |
| Investing Cash Flow | $-59.31MM | $-13.97MM | $-26.21MM |
| Financing Cash Flow | $0.96MM | $0.27MM | $24.18MM |
| Earnings Per Share** | $-4.42 | $-1.52 | $-0.84 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.